tbuckley/cabot-search huggingface dataset:
Strong Correlation Between Angiogenesis and Macrophage Counts in Waldenstrom’s Macroglobulinemia: Implications into the Biology of the Disease
Authors: Evangelos Terpos, Anna Tasidou, Efstathios Kastritis, Evangelos Eleutherakis-Papaiakovou, Dimitrios Christoulas, Maria Gavriatopoulou, Magdalini Migkou, Meletios A. Dimopoulos
Journal: Blood (2008)
A CpG island methylator phenotype in acute myeloid leukemia independent of IDH mutations and associated with a favorable outcome
Authors: A D Kelly, H Kroeger, J Yamazaki, R Taby, F Neumann, S Yu, J T Lee, B Patel, Y Li, R He, S Liang, Y Lu, M Cesaroni, S A Pierce, S M Kornblau, C E Bueso-Ramos, F Ravandi, H M Kantarjian, J Jelinek, J-PJ Issa
Journal: Leukemia (2017)
Socioeconomic disadvantage is linked to obesity across generations, UK study finds
Authors: Susan Mayor
Journal: BMJ (2017)

Socioeconomic disadvantage in childhood or as an adult is associated with higher body mass index (BMI) that persists with age and over different generations, longitudinal data from three national British birth cohorts of people born in 1946, 1958, and 1970 have shown.1

Previous studies have found that people with lower socioeconomic resources, both as children and adults, are more likely to have a higher BMI and increased risk of obesity in adulthood. …
Acute Renal Failure Following Myeloablative Autologous and Allogeneic Haematopoietic Cell Transplantation.
Authors: José A. Lopes, Edgar de Almeida, Sónia Silva, Sofia Jorge, Fernando Abreu, Fernanda Lourenço, Carlos Martins, João Forjaz Lacerda, José Alves do Carmo, João Manuel Forjaz Lacerda, Mateus Martins Prata
Journal: Blood (2005)
Delayed severe bleeding complications after treatment of pancreatic fluid collections with lumen-apposing metal stents
Authors: SS Stecher, P Simon, S Friesecke, A Glitsch, JP Kühn, MM Lerch, J Mayerle
Journal: Gut (2017)

With interest we read the paper by Bang et al ,1 who observed delayed severe adverse events after endoscopic treatment of pancreatic fluid collections (PFCs) with the Hot AXIOS lumen-apposing metal stent (LAMS), which was unrelated to the initial procedure, in a randomised controlled trial. LAMS are increasingly used for transmural endoscopic ultrasound-guided drainage of PFC and infected walled-off pancreatic necrosis (WOPN).2 Procedure associate bleeding is a frequent adverse event after transmural drainage.3 While our experience confirms our colleagues' findings we would like to emphasize that complications are not restricted to Hot AXIOS stents and that certain insertion techniques may be more prone to early bleeding while non-pigtail, LAMS can cause late bleeding complications.

From June 2013 to October 2016, we treated 46 patients with LAMS (8×Hot AXIOS 15×10 mm (Boston Scientific); 38×TAEWOONG MEDICAL Niti-S biliary covered stent (NAGI) …
Expression of specific inflammasome gene modules stratifies older individuals into two extreme clinical and immunological states
Authors: David Furman, Junlei Chang, Lydia Lartigue, Christopher R Bolen, François Haddad, Brice Gaudilliere, Edward A Ganio, Gabriela K Fragiadakis, Matthew H Spitzer, Isabelle Douchet, Sophie Daburon, Jean-François Moreau, Garry P Nolan, Patrick Blanco, Julie Déchanet-Merville, Cornelia L Dekker, Vladimir Jojic, Calvin J Kuo, Mark M Davis, Benjamin Faustin
Journal: Nature Medicine (2017)
Administration of All-Trans Retinoic Acid (ATRA) to Newly Diagnosed Patients (pts) with Acute Promyelocytic Leukemia (APL) Is Delayed Even At Experienced Centers and Associated with An Increased Early Death Rate (EDR): A Retrospective Analysis of 205 Pts
Authors: Jessica K. Altman, Alfred Rademaker, Elizabeth Cull, Bing Bing Weitner, Yishai Ofran, Todd L. Rosenblat, Augustin Haidau, Jae H. Park, Sharona Ram, James Orsini, Sonia Sandhu, Rose Catchatourian, Steven M. Trifilio, Nelly G. Adel, Olga Frankfurt, George Mallios, Tony Deblasio, Joseph G. Jurcic, Stephen Nimer, Jacob M. Rowe, Dan Douer, Martin S. Tallman
Journal: Blood (2011)
Rescue of Doxorubicin-Induced Chemoresistance by API 31510 in Chloroleukemia
Authors: Niven R Narain, Shuohan Wu, John P McCook, Rangaprasad R Sarangajan, Jasem M Alshaji, Maite Castillo, Lucia M Mauro, Joaquin J Jimenez
Journal: Blood (2011)
Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE
Authors: M.E. Otero, J.M. van den Reek, M.M. Seyger, P.C. van de Kerkhof, W. Kievit, E.M. de Jong
Journal: British Journal of Dermatology (2017)

As methotrexate (MTX) is a widely used treatment for psoriasis, it is important to gain insight into the reasons for the discontinuation of MTX and to understand the determinants for drug survival. To describe 5‐year drug survival for MTX in patients with psoriasis, split according to different reasons for discontinuation, and to identify the determinants for drug survival. Data were extracted from a prospective psoriasis registry of patients treated with MTX (MTX‐CAPTURE). Drug survival was analysed using Kaplan–Meier estimates and the determinants for discontinuation were analysed using Cox regression analysis. Analyses were split according to the reason for discontinuation: side‐effects or ineffectiveness. We included 85 patients treated with MTX, with a maximum treatment duration of 5·2 years. The overall drug survival rates were 63%, 30% and 15% after 1, 3 and 5 years, respectively. The median survival was 1·8 years. Overall, 55 patients (65%) discontinued MTX for the following reasons: side‐effects (35%), ineffectiveness (26%), combination of side‐effects and ineffectiveness (13%), other reasons (16%) and 11% were lost to follow‐up. The most reported side‐effects were gastrointestinal symptoms, despite the use of folic acid in 99% of patients. Based on univariate analysis, a high Psoriasis Area and Severity Index score and a high score on the visual analogue scale for disease severity at baseline were possible determinants for a short drug survival. Drug survival of MTX was low with 15% of patients 'on drug' after 5 years. Side‐effects alone or in combination with inadequate disease control were more important in the context of treatment discontinuation than inadequate disease control alone.
Rituximab in 42 Cases of French Childhood Auto-Immune Haemolytic Anaemia: High Efficiency but Caution Required
Authors: Stéphane Ducassou, Nathalie Aladjidi, Corinne Pondarre, Thierry Leblanc, Hervé Chambost, Armari-Alla Corinne, Pasquet Marlene, Helder Fernandes, Bayart Sophie, Piguet Christophe, Fouyssac Fanny, Monpoux Fabrice, Odile Lejars, Jeziorski Eric, Corinne Guitton, Guy Leverger, Yves Perel
Journal: Blood (2011)
Prospective Evaluation of Immune Hemolysis in Minor-ABO Incompatible Reduced-Intensity Peripheral Blood (PB) Hematopoietic Cell Transplantation (HCT).
Authors: W.T. Stevens, A.M. Reese, R. Wesley, D.F. Stroncek, E.J. Read, T. Donohue, A.S. Wayne, D.H. Fowler, B. Savani, A.J. Barrett, S.F. Leitman, R.W. Childs, C.D. Bolan
Journal: Blood (2005)
Effect of New Direct Oral Anticoagulants on Ex Vivo Platelet and Fibrin Thrombus Formation in Blood Flowing Over Fibrillar Type I Collagen
Authors: Grazia Loredana Mendolicchio, Corrado Lodigiani, Monica Bacci, Marco Scardino, Carlo Ferrari Matteo, Grappiolo Guido, Lidia Rota, Zaverio M. Ruggeri
Journal: Blood (2011)
Microtransplantation Improved Outcome in Elderly Acute Myeloid Leukemia Patients - Report from China Microtransplantation Cooperative Group
Authors: Mei Guo, Jianyong Li, Zheng Dong, Li Liu, Xuliang Shen, Xinrong Zhan, Depei Wu, Linhua Yang, Yangyi Bao, Xuzhang Lu, Changlin Yu, Jianhui Qiao, Kaixun Hu, Wanjun SUN, Hongli Zuo, Yajing Huang, Junxiao Qiao, Bo CAI, Zhiqing LIU, Tieqiang LIU, Bo Yao, Hongxia Zhao, Juan WANG, Qiyun SUN, Huisheng Ai
Journal: Blood (2015)
Genome sequencing reveals the origin of the allotetraploid <i>Arabidopsis suecica</i>
Authors: Polina Yu. Novikova, Takashi Tsuchimatsu, Samson Simon, Viktoria Nizhynska, Viktor Voronin, Robin Burns, Olga M. Fedorenko, Svante Holm, Torbjörn Säll, Elisa Prat, William Marande, Vincent Castric, Magnus Nordborg
Journal: Molecular Biology and Evolution (2017)

Polyploidy is an example of instantaneous speciation when it involves the formation of a new cytotype that is incompatible with the parental species. Because new polyploid individuals are likely to be rare, establishment of a new species is unlikely unless polyploids are able to reproduce through self-fertilization (selfing), or asexually. Conversely, selfing (or asexuality) makes it possible for polyploid species to originate from a single individual—a bona fide speciation event. The extent to which this happens is not known. Here, we consider the origin of Arabidopsis suecica, a selfing allopolyploid between Arabidopsis thaliana and Arabidopsis arenosa, which has hitherto been considered to be an example of a unique origin. Based on whole-genome re-sequencing of 15 natural A. suecica accessions, we identify ubiquitous shared polymorphism with the parental species, and hence conclusively reject a unique origin in favor of multiple founding individuals. We further estimate that the species originated after the last glacial maximum in Eastern Europe or central Eurasia (rather than Sweden, as the name might suggest). Finally, annotation of the self-incompatibility loci in A. suecica revealed that both loci carry non-functional alleles. The locus inherited from the selfing A. thaliana is fixed for an ancestral non-functional allele, whereas the locus inherited from the outcrossing A. arenosa is fixed for a novel loss-of-function allele. Furthermore, the allele inherited from A. thaliana is predicted to transcriptionally silence the allele inherited from A. arenosa, suggesting that loss of self-incompatibility may have been instantaneous.
Molecular Diagnosis of the First Ferroportin Mutation (C326Y) in the Far East Causing a Dominant Form of Inherited Iron Overload.
Authors: Vip Viprakasit, Alison T. Merryweather-Clarke, Yingyong Chinthammitr, Lisa Schimanski, Hal Drakesmith, Somdet Srichairatanakool, Chanin Limwongse, Alain Townsend, Kathryn J.H. Robson
Journal: Blood (2004)
Chronic Lymphocytic Leukemia in Venezuela: VH Mutation Status, Expression of ZAP-70, CD38 and Phenotypic Prevalence Among the Venezuelan Population.
Authors: Maria Elena Marquez, Pierre-Antoine Deglesne, Osiris Da Costa, Jose Luis Lopez, Mildred Borrego, Marcos Hernandez, Florence Ajchenbaum-Cymbalista, Guillermo Suarez, Jose Corado, Aixa Muller-Soyano, Egidio Romano
Journal: Blood (2009)
Recurrent Thrombosis in Patients with Polycythemia Vera or Essential Thrombocythemia: Efficacy of Treatment in Preventing Rethrombosis in Different Clinical Settings.
Authors: V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Mico’, A. Tieghi, R. Cacciola, C. Santoro, G. Gerli, P. Gugliemelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, Giuseppe Leone, T. Barbui
Journal: Blood (2006)
Control of Neutrophil Endothelial Transmigration By EC-18 in Chemotherapy Induced Neutropenia
Authors: Jae Wha Kim, Yong-Jae Kim, Young-Jun Kim, Sun Young Yoon, Jinseon Jeong, Young-Eun Ko, Su-Hyun Shin, Nina Yoo, Myung-Hwan Kim, Cheolwon Suh, Ki-Young Sohn, Heung-Jae Kim, Yong-Hae Han, Saeho Chong
Journal: Blood (2015)
Multifunctional Mitochondrial Epac1 Controls Myocardial Cell Death
Authors: Loubina Fazal, Marion Laudette, Sílvia Paula-Gomes, Sandrine Pons, Caroline Conte, Florence Tortosa, Pierre Sicard, Yannis Sainte-Marie, Malik Bisserier, Olivier Lairez, Alexandre Lucas, Jérôme Roy, Bijan Ghaleh, Jérémy Fauconnier, Jeanne Mialet-Perez, Frank Lezoualc’h
Journal: Circulation Research (2017)

Although the second messenger cyclic AMP (cAMP) is physiologically beneficial in the heart, it largely contributes to cardiac disease progression when dysregulated. Current evidence suggests that cAMP is produced within mitochondria. However, mitochondrial cAMP signaling and its involvement in cardiac pathophysiology are far from being understood.To investigate the role of MitEpac1 (mitochondrial exchange protein directly activated by cAMP 1) in ischemia/reperfusion injury.We show that Epac1 (exchange protein directly activated by cAMP 1) genetic ablation (Epac1-/-) protects against experimental myocardial ischemia/reperfusion injury with reduced infarct size and cardiomyocyte apoptosis. As observed in vivo, Epac1 inhibition prevents hypoxia/reoxygenation-induced adult cardiomyocyte apoptosis. Interestingly, a deleted form of Epac1 in its mitochondrial-targeting sequence protects against hypoxia/reoxygenation-induced cell death. Mechanistically, Epac1 favors Ca2+ exchange between the endoplasmic reticulum and the mitochondrion, by increasing interaction with a macromolecular complex composed of the VDAC1 (voltage-dependent anion channel 1), the GRP75 (chaperone glucose-regulated protein 75), and the IP3R1 (inositol-1,4,5-triphosphate receptor 1), leading to mitochondrial Ca2+ overload and opening of the mitochondrial permeability transition pore. In addition, our findings demonstrate that MitEpac1 inhibits isocitrate dehydrogenase 2 via the mitochondrial recruitment of CaMKII (Ca2+/calmodulin-dependent protein kinase II), which decreases nicotinamide adenine dinucleotide phosphate hydrogen synthesis, thereby, reducing the antioxidant capabilities of the cardiomyocyte.Our results reveal the existence, within mitochondria, of different cAMP-Epac1 microdomains that control myocardial cell death. In addition, our findings suggest Epac1 as a promising target for the treatment of ischemia-induced myocardial damage.
Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.
Authors: Dieter Hoelzer, Eckhard Thiel, Renate Arnold, Joachim Beck, Dietrich W. Beelen, Martin Bornhäuser, Donald Bunjes, Diana Ditz, Ulrich Dührsen, Jörg Finke, Heinz A Horst, Guido Kobbe, Hans Jochem Kolb, Karl Anton Kreuzer, Nicolaus Kröger, Thomas Lipp, Markus Schaich, Mathias Schmid, Stefan Schwartz, Rainer Schwerdtfeger, Hubert Serve, Reingard Stuhlmann, Knut Wendelin, Christof Scheid, Nicola Gökbuget
Journal: Blood (2009)
Prospective Phase III Trial of Valproic acid (VPA) In Combination with All-Trans Retinoic Acid (ATRA) and Intensive Induction Therapy for AML In Older Patients: The German-Austrian AMLSG 06-04 Study
Authors: Michela Tassara, eronika Hofer, Konstanze Döhner, Marie Lilienfeld-Toal, Gerhard Held, Katharina Götze, Heinz A. Horst, Sibylla Wilhelm, Stephan Kremers, Elisabeth Koller, Daniela Späth, Silja Mack, Carina Morlok, Martin Göttlicher, Hartmut Döhner, Richard F. Schlenk
Journal: Blood (2010)
Don’t let May trample on the NHS
Authors: Fiona Godlee
Journal: BMJ (2017)

News that Theresa May will feature in US Vogue magazine has added to what Martin McKee calls “the uncomfortable disconnect between her words and actions” (doi:10.1136/bmj.j213). Her homily on the steps of 10 Downing Street six months ago, including sentiments that she repeated in a speech last week, suggests deep concern about people who are struggling to get by—the “just about managing.” Her actions as home secretary and now as prime minister give no such comfort.

The United Kingdom is one of the most unequal societies in the developed world (www.bbc.co.uk/news/business-37341095), and despite it also …
Apoptosis and Cell Cycle Regulatory Gene Expression in Adult De Novo Myelodysplastic Syndromes (MDS)
Authors: Christina Economopoulou, Vassiliki Pappa, S. Papageorgiou, F. Kontsioti, P Economopoulou, Ef Charitidou, K Girkas, P. Tsirigotis, J Dervenoulas, E. Papageorgiou, T Economopoulos
Journal: Blood (2008)
Inhibition of SYK More Effectively Overcomes MCL-1 Mediated ABT-199 Resistance of BCR-Stimulated CLL Cells Than Inhibition of BTK or PI3Kdelta
Authors: Kamil Bojarczuk, Binu K Sasi, Stefania Gobessi, Idanna Innocenti, Luca Laurenti, Dimitar G Efremov
Journal: Blood (2015)
High Expression of IL-15 Correlates with Disease Recurrence of Adult B-Lineage Acute Lymphoblastic Leukemia
Authors: Shuling Wu, Lars Fischer, Thomas Burmeister, Stefan Schwartz, Michael Notter, Nicola Gökbuget, Dieter Hoelzer, Wolf-Karsten Hofmann, Eckhard Thiel
Journal: Blood (2008)
6q12 and 11p14 variants are associated with postnatal exhaled nitric oxide levels and respiratory symptoms
Authors: Oliver Fuchs, Olga Gorlanova, Philipp Latzin, Anne Schmidt, Maximilian Schieck, Antoaneta A. Toncheva, Sven Michel, Vincent D. Gaertner, Michael Kabesch, Urs Frey
Journal: Journal of Allergy and Clinical Immunology (2017)
Phase I/IB Study of Azacitidine and Hedgehog Pathway Inhibition in Myeloid Malignancies
Authors: Raoul Tibes, Heidi E. Kosiorek, Amylou C. Dueck, Lisa Sproat, Jeanne Palmer, James L. Slack, Devinder Singh, Eileen Gebhart, Emily Knight, Shahrukh K. Hashmi, Ryan A Wilcox, James M Bogenberger, Ruben A. Mesa, Aref Al-Kali
Journal: Blood (2015)
Reply to Thomas Zilli, Gilles Créhange and Olivier Chapet's Letter to the Editor re: Pascal Rischmann, Albert Gelet, Benjamin Riche, et al. Focal High Intensity Focused Ultrasound of Unilateral Localized Prostate Cancer: A Prospective Multicentric Hemiablation Study of 111 Patients. Eur Urol 2017;71:267–73
Authors: Pascal Rischmann
Journal: European Urology (2017)
TCT-810 Assessment of Doubtful Aortic Stenosis by Measuring Simultaneous Transaortic Pressure: A Pilot Study With Fractional Flow Reserve Guidewire
Authors: Romain Chopard, Marie-France Seronde, Sebastien Janin, Philoktimon Plastaras, Nicolas Meneveau, Francois Schiele
Journal: Journal of the American College of Cardiology (2012)
Abstract B40: P-selectin is a nanotherapeutic delivery target to the tumor microenvironment
Authors: Daniel A. Heller
Journal: Cancer Research (2017)

Abstract Disseminated tumors are poorly accessible to nanoscale drug delivery systems due to the vascular barrier, which attenuates extravasation at the tumor site. We investigated P-selectin, a molecule expressed on activated vasculature that facilitates metastasis by arresting tumor cells at the endothelium, for its potential to target metastases using this property. We found unexpectedly that P-selectin is expressed on cancer cells in many human tumors. To develop a targeted drug delivery platform, we employed a polysaccharide with nanomolar affinity to P-selectin. The nanoparticles targeted the tumor microenvironment to localize chemotherapeutics and a targeted MEK inhibitor at tumor sites in both primary and metastatic models, resulting in superior anti-tumor efficacy. On non-expressing tumors, we found that ionizing radiation guided the nanoparticles to the disease site by inducing P-selectin expression. Radiation concomitantly produced an abscopal-like phenomenon in unirradiated tumors, suggesting a potential strategy to target disparate drug classes to almost any tumor. Citation Format: Daniel A. Heller. P-selectin is a nanotherapeutic delivery target to the tumor microenvironment. [abstract]. In: Proceedings of the AACR Special Conference on Engineering and Physical Sciences in Oncology; 2016 Jun 25-28; Boston, MA. Philadelphia (PA): AACR; Cancer Res 2017;77(2 Suppl):Abstract nr B40.
Honokiol Overcomes Conventional Drug Resistance in Human Multiple Myeloma.
Authors: Kenji Ishitsuka, Teru Hideshima, Makoto Hamasaki, Raje Noopur, Kumar Shaji, Hiromasa Hideshima, Norihiko Shiraishi, Paul Richardson, Nikhil C. Munshi, Dharminder Chauhan, Jack Arbiser, Kenneth C. Anderson
Journal: Blood (2004)
PTU-005 Risk Factors for Recurrence Following Endoscopic Resection of Large Colorectal Polyps in a Western Population
Authors: A Emmanuel, S Gulati, M Burt, B Hayee, A Haji
Journal: Gut (2016)

<h3>Introduction</h3> Although consistent risk factors for recurrence after resection of colorectal polyps have been identified in eastern series, there are few data on risk factors in western practice which may have different patient populations, experience, referral patterns and employ different techniques. Our unit is one of only a few specialist interventional endoscopy units in the UK. As a result, many referred patients have very large polyps, deeply scarred lesions from previous attempts at resection and several had been deemed too frail to undergo treatment. We aimed to determine the risk factors for recurrence after endoscopic resection of large colorectal polyps in this population. <h3>Methods</h3> We analysed a series of endoscopic resections of large colorectal polyps. Several techniques were employed including EMR, ESD and hybrid techniques involving combinations of EMR, ESD, TEMS and transanal resection for particularly challenging polyps. Visible vessels were routinely coagulated. After resection, the area was scrutinised with magnification chromoendoscopy to check for residual polyp which was resected or ablated. Surveillance endoscopy was performed at 3 and 12 months. <h3>Results</h3> 363 polyps with a mean size of 56 mm were resected in 326 patients who had a mean age of 71 years: 309 by EMR, 38 by ESD and 16 by hybrid procedures. Mean follow up was 12.2 months. 38% of polyps were deeply scarred. Recurrence occurred in 9.7% of patients, 17% of which were diminutive. 66% of recurrences were apparent on the first surveillance endoscopy. Size &gt; 30 mm, piecemeal resection, deeply scarred lesions and the use of argon plasma coagulation were associated with recurrence on univariate analysis. However, logistic regression revealed only piecemeal resection was independently associated with recurrence (OR 5.1, p = 0.03). Intraprocedural bleeding, old age, high grade dysplasia, rectal location and histological type were not significantly associated with recurrence. Furthermore, there were no significant differences in recurrence between lesions resected by ESD or EMR, or between lesions resected with traditional techniques and those using a hybrid of various endoscopic and minimally invasive surgical techniques. <h3>Conclusion</h3> In contrast to other series, we found only piecemeal resection to be associated with recurrence. We feel that the routine use of techniques such as post-resection assessment using magnification chromoendoscopy to detect residual polyp and routine coagulation of visible vessels helps to eliminate some of the risk factors for recurrence. These techniques may also account for the success of hybrid procedures to resect large polyps in difficult locations with similar recurrence rates, which are an invaluable option in some challenging cases. <h3>Disclosure of Interest</h3> None Declared
PD0332991, a CDK4/6 Inhibitor, Has An Anti-Leukemic Activity Against Lymphoid Crisis of CML and Ph+ALL Even with T315I Mutation in BCR-Abl; in Vitro Analysis
Authors: Atsushi Nemoto, Takeshi Inukai, Koshi Akahane, Hiroko Honna- Oshiro, Kumiko Goi, Keiko Kagami, Yasuhiro Maeda, Tetsuzo Tauchi, Shinya Kimura, Kanji Sugita
Journal: Blood (2011)
Relevance of αβ-DNTs as Prognostic Factor on Clinical Outcome and Role on Tumor Surveillance in Haematological Diseases and Solid Tumor: Preliminary Evaluations
Authors: Giacoma De Tullio, Carla Minoia, Margherita Gigante, Sabino Strippoli, Simona Serratì, Giacomo Loseto, Rosa Angarano, Nicola Sgherza, Vincenza De Fazio, Antonello Rana, Angela Iacobazzi, Michele Guida, Elena Ranieri, Pasquale Iacopino, Attilio Guarini
Journal: Blood (2014)
Multilineage Dysplasia Has No Prognostic Impact in 108 Adult Patients with CEBPA Mutated AML Supporting the WHO Proposal to Classify These Patients As A Molecularely Defined Unique Entity
Authors: Torsten Haferlach, Ulrike Bacher, Katja Macijewski, Vera Grossmann, Alexander Kohlmann, Tamara Alpermann, Wolfgang Kern, Claudia Haferlach, Susanne Schnittger
Journal: Blood (2011)
Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab
Authors: Tahamtan Ahmadi, Elise A. Chong, Amanda Gordon, Leah Leinbach, Nicole A. Aqui, Sunita D. Nasta, Jakub Svoboda, Steven C. Goldstein, Stephen J. Schuster
Journal: Blood (2010)